Journal
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
Volume 45, Issue 2, Pages 158-160Publisher
INFORMA HEALTHCARE
DOI: 10.3109/00365548.2012.704152
Keywords
Chronic hepatitis B; nucleoside analogues; pathological examination
Categories
Ask authors/readers for more resources
Lamivudine, adefovir, telbivudine, and entecavir are nucleoside analogues that can inhibit hepatitis B virus replication and are licensed in China by the Food and Drug Administration. This study presents the cases of 2 patients who were chronically infected with HBV and suffered hepatic failure resulting from withdrawal of telbivudine and adefovir, respectively.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available